About Amy Peters, PhD
Amy Peters, PhD, received her undergraduate degree from Boston College and her doctoral degree in Clinical Psychology from the University of Illinois at Chicago. She completed her predoctoral clinical internship in neuropsychology (2018) at the University of Illinois at Chicago and is a licensed psychologist in the state of Massachusetts. She completed her postdoctoral research fellowship (2020) in the Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital and joined the faculty as Instructor of Psychology (2020). Dr. Peters is a past recipient of the Samuel Gershon Junior Investigator Award from the International Society for Bipolar Disorder and an Early Career Investigator Award from the Society for Biological Psychiatry.
Treats:
- Adult
Medical Education
- PhD, University of Illinois at Chicago Medical Center
- Fellowship, Massachusetts General Hospital*
Accepted Insurance Plans
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- Cigna Behavioral Health
- Commonwealth Care Alliance
- Great-West Healthcare (formally One Health Plan)
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- MassHealth
- Medicare
- Medicare - ACD
- Medicare ACO - ACD
- Medicare ACO - PBO
- OSW - Connecticut
- OSW - Maine
- OSW - New Hampshire
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Behavioral Health
- United Behavioral Health - MGH
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Amy Peters' research focuses on the etiology of cognitive dysfunction and its role in the development, course, and treatment of mood disorders. This includes a specific interest in how immune and endocrine biomarkers impact the brain networks underlying cognition and mood. The goal of this research is to identify neural and molecular risk factors that could be targeted with new treatments to improve cognitive functioning. Her research has been funded by the National Institute for Mental Health and the American Psychological Foundation.